ChromaCode and Protean BioDiagnostics Establish Strategic Partnership to Introduce a HDPCR-based NSCLC Assay in the U.S. August 10, 2023
ChromaCode Announces Commercial Availability of HDPCR-based Non-Small-Cell Lung Cancer Assay July 11, 2023
ChromaCode Announces Partnership with MedGenome to Bring HDPCR-based Diagnostics to India and the Middle East April 27, 2023
